PubMed · 1991 · 30 citations · 0 references
Life SciencesNeurosciencePharmacologyMemoryNeuropharmacologySynaptic PlasticityCholinergic PharmacologyGlutamatergic PharmacologyLong-term PotentiationMemory ConsolidationNeurotransmissionSynaptic TransmissionHippocampal Long-term PotentiationKetamine PharmacologyKetamine TreatmentNmda Receptor AntagonismNmda Receptor AntagonistsNmda Receptor FunctionNmda Receptor PharmacologyNmda Receptors
The phenomenon of long-term potentiation (LTP) formation in hippocampal and neocortical brain areas has been suggested as a mechanism for learning and memory where NMDA-receptors play a significant role. Various agonists have been proposed to facilitate LTP and thereby learning and memory. Competitive and non-competitive antagonists of NMDA-receptors block LTP formation and produce attentional or acquisition deficit in animals. A series of experiments were carried out with noncompetitive NMDA antagonists, MK-801 (10-100 micrograms/kg) and ketamine (1-10 mg/kg), in passive avoidance step-down task paradigm in mice. MK-801 showed complete disruption of acquisition at higher doses, while very low doses showed improvement in retention. MK-801 showed additive or potentiating influence on scopolamine-induced deficits. The results of the interaction of NMDA antagonists with scopolamine provide a basis for the speculation that cholinergic- and NMDA-antagonism may play a hand in hand role in short-term memory disturbances in passive avoidance step-down task paradigm in mice.